相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification
V. Lezaic et al.
CLINICAL NEPHROLOGY (2011)
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials
Sankar D. Navaneethan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients
Christopher W. McIntyre et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: A pilot study
David M. Spiegel et al.
HEMODIALYSIS INTERNATIONAL (2009)
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis
Pieter Evenepoel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis
Juan F. Navarro-Gonzalez et al.
SEMINARS IN DIALYSIS (2009)
Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study
Ron Wald et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The calcium acetate renagel evaluation-2 (CARE-2) study
Wajeh Qunibi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Serum phosphate levels and risk of infection in incident dialysis patients
Laura C. Plantinga et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis
Faruk Turgut et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial
Ioannis P. Tzanakis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD
Gerard M. London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study
David M. Spiegel et al.
JOURNAL OF RENAL NUTRITION (2007)
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
D. Russo et al.
KIDNEY INTERNATIONAL (2007)
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
Marcello Tonelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
The role of magnesium binders in chronic kidney disease
David M. Spiegel
SEMINARS IN DIALYSIS (2007)
Calcium-based phosphate binders are appropriate in chronic renal failure
Eli A. Friedman
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
HG Asmus et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2005)
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)
WY Qunibi et al.
KIDNEY INTERNATIONAL (2004)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher et al.
LANCET (2001)
分享论文
